Skip to main content
eBioMedicine logoLink to eBioMedicine
. 2020 Nov 10;62:103127. doi: 10.1016/j.ebiom.2020.103127

Corrigendum to ‘Phosphorylated Rasal2 facilitates breast cancer progression’

[EBioMedicine 50 (2019) 144–155]

Xuan Wang a,c, Christopher Qian b, Yinlong Yang d, Meng-Yue Liu a, Ya Ke b,, Zhong-Ming Qian a,c,
PMCID: PMC7658475  PMID: 33181465

In this Research Paper, the affiliations of the following authors should have been as follows:

Xuan Wang (a,c), Meng-Yue Liu (a), Zhong-Ming Qian (a,c)

As a result, the order in which two of the institutions were listed changes to:

(a) Institute of Translational & Precision Medicine, Nantong University, 19 Qi Xiu Road, Nantong, JS 226019, China

(c) Department of Pharmacology and Biochemistry, Fudan University School of Pharmacy, 826 Zhangheng Road, Pu Dong, Shanghai 201203, China.

The authors apologise for this oversight.

Footnotes


Articles from EBioMedicine are provided here courtesy of Elsevier

RESOURCES